While Venn Life looks for a successor, Chief Executive Tony Richardson will take over Hartshorn's responsibilities.
Shares were down 1.7% on Wednesday at
Wed, 21st Mar 2018 11:03
While Venn Life looks for a successor, Chief Executive Tony Richardson will take over Hartshorn's responsibilities.
Shares were down 1.7% on Wednesday at
(Alliance News) - Shares in Open Orphan PLC began trading in London on Friday following the combination of Venn Life Sciences Holdings PLC and Open Orphan DAC.Venn Life Sciences announced a
Read moreLONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - up 2.5%, BHP Group, up up a
Read moreLONDON (Alliance News) - Venn Life Sciences Holdings PLC on Tuesday said it has conditionally raised GBP4.5 million before expenses through a share placing as its loss widened in 2018.The a
Read moreLONDON (Alliance News) - Venn Life Sciences Holdings PLC on Friday said it is acquiring Open Orphan DAC in an all-share acquisition and planning an equity fundraise.In addition, Venn it has
Read moreLONDON (Alliance News) - Venn Life Sciences Holdings PLC on Monday said Raglan Capital Ltd, of whom Cathal Friel is a principal and owner, has subscribed for loan notes of GBP250,000 with a term -
Read moreLONDON (Alliance News) - Venn Life Sciences Holdings PLC on Friday said it has collaborated with Carrick Therapeutics Ltd to develop innovative cancer treatments.The drug development said a
Read more(Sharecast News) - Integrated drug development company Venn Life Sciences announced a partnership with Carrick Therapeutics on Friday.
Read more(Sharecast News) - Integrated drug development company Venn Life Sciences announced a strategic collaboration with Open Orphan DAC, as well as the issue of £1m in privately-held loan notes on Tuesday, to fund an increased focus of the business into the high growth area of orphan diseases.
Read moreLONDON (Alliance News) - Venn Life Sciences Holdings PLC said Tuesday it entered a strategic collaboration with Open Orphan DAC.Under the collaboration, both companies will commit to and to
Read moreLONDON (Alliance News) - Drug development firm Venn Life Sciences Holdings PLC said Tuesday its half-year loss widened as revenue dropped on delays to the conversion of orders to sales.For
Read moreLONDON (Alliance News) - Venn Life Sciences Holdings PLC said Monday that Spreadex Ltd held a 5.5% stake in the drug developer after a Tuesday transaction.Through a combination of contracts
Read moreLONDON (Alliance News) - Drug development partner to pharmaceutical companies Venn Life Sciences Holdings PLC said Wednesday it raised up to GBP650,000 issuing 10.8 million shares at 6 pence was a
Read moreThursday 21 JuneHSS Hire GroupFriday 22 JuneCambian Fifteen Communications Shipping 25
Read moreLONDON (Alliance News) - Venn Life Sciences Holdings PLC said on Thursday its loss for 2017 widened due to higher impairments on fixed asset investments, as well as lower revenue for the drug and
Read more